Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas

Leuk Lymphoma. 2021 Jan;62(1):95-103. doi: 10.1080/10428194.2020.1821011. Epub 2020 Sep 23.

Abstract

Extranodal NK/T cell lymphomas (ENKTCLs) are aggressive Epstein-Barr virus-associated T/NK neoplasms that predominantly affect Asians. To explore the causative somatic events, we conducted a comprehensive genetic analysis of 19 ENKTCL patients by whole-genome (N = 2), whole-exome (N = 16), and targeted sequencing (N = 15). Commonly deregulated gene pathways in ENKTCLs included epigenetic modifiers (58%, 11/19) followed by human leukocyte antigens (HLAs) and related genes including HLA-A, B2M, TAP1, CD274, and PDCD1LG2 (32%, 6/19), and JAK-STAT pathway (26%, 5/19). Conspicuously, loss-of-function mutations in HLA-A were recurrently identified in ENKTCLs (16%, 3/19). HLA protein expression was examined by immunohistochemistry in 16 patients and lower expression was associated with advanced stages at presentation (p = .007). In conclusion, the defective antigen presenting pathway is common and related to disease progression, suggesting immune escape as a pathogenic mechanism of ENKTCLs.

Keywords: Epstein–Barr virus; HLA; extranodal NK/T cell lymphomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epstein-Barr Virus Infections*
  • Herpesvirus 4, Human
  • Humans
  • Immunohistochemistry
  • Lymphoma, Extranodal NK-T-Cell* / genetics
  • Mutation